St. Bernward Krankenhaus GmbH

The trials here

What the 11 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer4 trials
• Hodgkin lymphoma2 trials
• Acute myeloid leukaemia1 trial
• Chronic lymphocytic leukaemia1 trial
• Diffuse large B-cell lymphoma1 trial
• Follicular lymphoma1 trial
• Immune thrombocytopenia (ITP)1 trial
• Multiple myeloma1 trial
• Prostate cancer1 trial

Phase

• Phase 37 trials
• Phase 21 trial

Status

• Recruiting5 trials
• Completed3 trials
• Active, not recruiting2 trials
• Not yet recruiting1 trial

Lead sponsor

• University Of Cologne2 trials
• Celgene1 trial
• Charite University, Berlin, Germany1 trial
• Heidelberg University1 trial
• Jena University Hospital1 trial
• and 5 more

Running trials

• Not yet recruiting

  Continuous or Intermittent Cetuximab Plus FOLFIRI as First-line Treatment in RAS/BRAF Wild-type mCRC Patients

  NCT07004413· Phase 3· Charite University, Berlin, Germany· Source

• Recruiting

  A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration (15 cycles) venetoclax/ pirtobrutinib vs. MRD-guided venetoclax/ pirtobrutinib in patients with previously untreated chronic lymphocytic leukaemia (CLL)/ small lymphocytic lymphoma (SLL) aiming to establish measurement of individual residual disease for adjustment of treatment duration to improve outcomes (CLL18/ MOIRAI)

  2023-510294-34-00· Phase 3· University Of Cologne· Source

• Recruiting

  Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML

  NCT05904106· Phase 2· Technische Universität Dresden· Source

• Recruiting

  PROCARE - PROstate Cancer Real World Evidence Registry

  NCT06835218· UroTrials Company (GmbH)· Source

  Contact: Ulrich Kaiser, Professor

• Recruiting

  Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma

  NCT05820841· Phase 3· Universität des Saarlandes· Source

• Recruiting

  ITP Registry and Accompanying Biospecimen Collection

  NCT05152238· Jena University Hospital· Source

  Contact: Ulrich Kaiser, Prof. Dr.

• Active, not recruiting

  Short RT Versus RCT,Followed by Chemo and Organ Preservation for Interm and High-risk Rectal Cancer Patients

  NCT04246684· Phase 3· Prof. Dr. med. Claus Rödel· Source

• Active, not recruiting

  FOLFOX before surgey compared to risk-adapted chemotherapy after surgery in patients with locally advanced rectal cancer and low risk for local failure

  NCT04495088· Phase 3· Heidelberg University· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Colorectal cancer1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Follicular lymphoma1 recruiting
• Hodgkin lymphoma1 recruiting
• Immune thrombocytopenia (ITP)1 recruiting
• Prostate cancer1 recruiting

Closed trials

• Completed

  CIRCULATE

  NCT04089631· Phase 3· Technische Universitat Dresden· Source

• Completed

  A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant

  NCT03106324· Celgene· Source

• Completed

  HD21

  NCT02661503· Phase 3· University Of Cologne· Source